{"cluster": 16, "subcluster": 0, "abstract_summ": "Recent studies and international statistics have shown an increased prevalence, morbidity as well as mortality of this disease in male patients compared to female patients.In the recent coronavirus disease (COVID-19) outbreak, a higher proportion of patients with severe disease were found in older persons with comorbidities.The paper of Cheng H. et al., describes an interesting hypothesis regarding the organ protective effects of ACE2 activation against the malignant effects of SARS-CoV-2 infection in humans, and describes interesting previous results reporting ACE2 higher levels in children, young people and women that is coincident with a lower morbidity and health problems associated to COVID19.I had started to investigate the same idea and think that I have discovered a wealth of additional supporting information that renders the hypothesis plausible and, if correct, could establish lower TLR7 activity/sensitivity as a common molecular characteristic of several high-risk patient groups.This paper reviews data about the use of DPP-4 inhibitors and others diabetes drugs on COVID-19 patients.", "title_summ": "Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19COVID\u201019: Social distancing, ACE 2 receptors, protease inhibitors and beyond?COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?Could the smoking gun in the fight against Covid-19 be the (rh) ACE2?THERAP\u2013COVID-19ACE2 activators for the treatment of COVID 19 patientsIs the ACE2 Overexpression a Risk Factor for COVID-19 Infection?Is DPP4 inhibition a comrade or adversary in COVID-19 InfectionCOVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptorTMPRSS2 and COVID-19: Serendipity or opportunity for intervention?Diabetes and COVID-19.A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?", "title_abstract_phrases": "Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?In the recent coronavirus disease (COVID-19) outbreak, a higher proportion of patients with severe disease were found in older persons with comorbidities.May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?This paper reviews data about the use of DPP-4 inhibitors and others diabetes drugs on COVID-19 patients.Is DPP4 inhibition a comrade or adversary in COVID-19 InfectionHypertension and Diabetes are the most common comorbid conditions in patients with COVID-19 and has been shown to adversely impact prognosis globally.Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19A major unanswered question in the current global COVID-19 outbreak is why a small minority of infected individuals develop severe disease."}